Risk assessment for the amino acids taurine, L-glutamine and L-arginine.
about
Taurine: the appeal of a safe amino acid for skeletal muscle disordersEffects of amino acid derivatives on physical, mental, and physiological activitiesTaurine provides neuroprotection against retinal ganglion cell degenerationMetabolomics Coupled with Multivariate Data and Pathway Analysis on Potential Biomarkers in Cholestasis and Intervention Effect of Paeonia lactiflora Pall.Succinic semialdehyde dehydrogenase deficiency: lessons from mice and menThe potential protective effects of taurine on coronary heart disease.Evidence-based recommendations for natural bodybuilding contest preparation: nutrition and supplementationTaurine does not affect the composition, diversity, or metabolism of human colonic microbiota simulated in a single-batch fermentation system.The potential usefulness of taurine on diabetes mellitus and its complications.Immune Function and Muscle Adaptations to Resistance exercise in Older Adults: Study Protocol for a Randomized Controlled Trial of a Nutritional Supplement.L-Arginine enhances cell proliferation and reduces apoptosis in human endometrial RL95-2 cells.Arginine metabolism and nutrition in growth, health and diseaseThe effect of acute taurine ingestion on 4-km time trial performance in trained cyclistsL-Arginine as a potential ergogenic aid in healthy subjects.Vigabatrin-associated retinal damage: potential biochemical mechanisms.Mechanism of the protective action of taurine in toxin and drug induced organ pathophysiology and diabetic complications: a review.The diagnosis and treatment of myotonic disorders.Protein and amino acid supplementation in older humans.The effect of taurine on chronic heart failure: actions of taurine against catecholamine and angiotensin II.BIOACTIVE PROTEINS, PEPTIDES, AND AMINO ACIDS FROM MACROALGAE(1).Catabolism and safety of supplemental L-arginine in animals.Safety and performance benefits of arginine supplements for military personnel: a systematic review.Safety and Effectiveness of Arginine in Adults.The Safety and Regulatory Process for Amino Acids in Europe and the United States.The Importance of Quality Specifications in Safety Assessments of Amino Acids: The Cases of l-Tryptophan and l-Citrulline.Clinical use of amino acids as dietary supplement: pros and cons.Antidepressant effect of taurine in chronic unpredictable mild stress-induced depressive rats.Oral arginine improves linear growth of long bones and the neuroendocrine mechanism.Taurine: A Potential Ergogenic Aid for Preventing Muscle Damage and Protein Catabolism and Decreasing Oxidative Stress Produced by Endurance Exercise.Taurine and vitamin E supplementations have minimal effects on body composition, hepatic lipids, and blood hormone and metabolite concentrations in healthy Sprague Dawley rats.Sulfasalazine-induced renal and hepatic injury in rats and the protective role of taurine.Boosting endogenous production of vasoprotective hydrogen sulfide via supplementation with taurine and N-acetylcysteine: a novel way to promote cardiovascular health.Detection of inflammatory cell function using (13)C magnetic resonance spectroscopy of hyperpolarized [6-(13)C]-arginine.Mitigation of Methimazole-Induced Hepatic Injury by Taurine in Mice.Nutrient reference values for bioactives: new approaches needed? A conference report.Beneficial effects of high dose taurine treatment in juvenile dystrophic mdx mice are offset by growth restriction.The effect of acute taurine ingestion on 3-km running performance in trained middle-distance runners.Role of myeloperoxidase in abdominal aortic aneurysm formation: mitigation by taurine.Scientific Opinion on the safety and efficacy of taurine as a feed additive for all animal speciesBenefits of Prenatal Taurine Supplementation in Preventing the Onset of Acute Damage in the Mdx Mouse.
P2860
Q26799770-3A6E38DC-FEA0-49AF-A2F1-C92FB018F390Q28302810-710EE3EA-8645-44C1-8387-45A563A2476DQ28484543-17B12A08-9D82-4BAE-806A-6C6D2F9E9F35Q31044588-9744DCAA-84A0-46A8-9B04-DDD7849506EAQ33403217-F08332EB-EF6A-4A28-9C10-E74027A8C7C9Q33618336-BB9D0C74-C382-4FD7-8CB9-44AD045E7AE8Q33661388-3229301B-BF18-4C9C-9132-2C2CDFD7CA16Q33897850-FF801AA8-5A5B-4AB6-8E76-20476B0FA0C3Q34627951-147CDF82-215B-4A2C-AF39-B728F3344AA9Q35544504-CA76FFC8-CFBA-4343-80CA-9B0A8ECEBC1BQ36686919-F4CD979D-9F7E-4586-B053-80C594DADB06Q37179500-46C68B22-D75F-4E6F-AEE8-55DB2FF8B354Q37355099-0EB80978-1CA9-461F-A730-E99F90A19CC2Q37851964-C9CD3596-2027-42B8-9C71-2C9239DF90BCQ38013194-BC5D8321-BA66-4921-8BEA-3824C2CCB0A6Q38038803-9401C4FA-70AC-4C0F-AD2B-A1732EADA56CQ38093802-CA040C2C-CD0D-419B-9690-BECBE2DAF470Q38096904-B0924DFE-397A-40EF-9108-110ECEFF4C29Q38110697-29712120-FDF0-4E2F-9722-579697A13C77Q38791850-EBA31D2D-66D1-401F-ACB3-D8DA3F9FE733Q38828416-C4B54B18-8EBA-4603-BD7C-6800540274F3Q38983830-BB3954E8-17E6-47EC-BE19-B649FB7057F9Q39033968-0270AE5B-4720-45A6-895F-7A7A7C6D1637Q39033992-EF4B7022-CE6D-45AC-B27B-3D0009B02866Q39033996-73E31765-9049-4E06-B630-9FC00686FCE5Q39727792-11A27CFA-B2DD-411D-B36A-474D9B67E3C8Q40974102-ED6FF18A-2A83-4D77-93BB-1DE453B8FC84Q41442426-63980E6D-B7C4-44BB-8EFA-AC8200955D82Q41867028-F38598EB-1E80-4C8F-87C3-231781793C6FQ41882081-14BD140E-2D96-456D-ABDF-F5EFE039697AQ42183819-306944E4-0EB8-4FD4-8401-19671608B06EQ42338456-5A8E1CBF-1666-4044-8947-4A51CB402C4AQ42368949-3272C510-A7F5-4DA4-B483-8FE524D12001Q43067087-979EBF79-263C-468F-8148-7352EE28E1ACQ43229172-A37B424F-7858-4C22-AA08-6D5614F44140Q43845526-8B429260-F394-4CE7-BEB7-39AA83F9DDCAQ45346706-4329691A-3D3C-4B58-AC36-D7867C57BA2BQ46296444-1C79726C-45BF-480B-BCAC-37BD5ABA8BF9Q47151885-F32219AE-A845-4BC1-91D6-75EB98579F22Q47349229-62CE3F0D-DA37-47C1-9628-59B8DC606901
P2860
Risk assessment for the amino acids taurine, L-glutamine and L-arginine.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Risk assessment for the amino acids taurine, L-glutamine and L-arginine.
@ast
Risk assessment for the amino acids taurine, L-glutamine and L-arginine.
@en
Risk assessment for the amino acids taurine, L-glutamine and L-arginine.
@nl
type
label
Risk assessment for the amino acids taurine, L-glutamine and L-arginine.
@ast
Risk assessment for the amino acids taurine, L-glutamine and L-arginine.
@en
Risk assessment for the amino acids taurine, L-glutamine and L-arginine.
@nl
prefLabel
Risk assessment for the amino acids taurine, L-glutamine and L-arginine.
@ast
Risk assessment for the amino acids taurine, L-glutamine and L-arginine.
@en
Risk assessment for the amino acids taurine, L-glutamine and L-arginine.
@nl
P1476
Risk assessment for the amino acids taurine, L-glutamine and L-arginine.
@en
P2093
Andrew Shao
John N Hathcock
P304
P356
10.1016/J.YRTPH.2008.01.004
P407
P577
2008-01-26T00:00:00Z